RUCONEST® (C1 esterase inhibitor [recombinant]) A Recombinant C1INH Treatment Option
Sunday, March 6, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon E
0.00 CME/CE
This program is not sponsored or programmed by the AAAAI.

Sponsored by Salix Pharmaceuticals.


Marc Riedl, MD

Professor of Medicine

Clinical Director – US HAEA Angioedema Center

Division of Rheumatology, Allergy and Immunology

University of California

San Diego, California